HCA_AIVITA AV-GBM-1 141-18

Phase II trial of autologous dendritic cells loaded with autologous tumor associated antigens (AV-GBM-1) as an adjunctive therapy following primary surgery plus concurrent chemoradiation in patients with newly diagnosed glioblastoma.

PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH AUTOLOGOUS TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING PRIMARY SURGERY PLUS CONCURRENT CHEMORADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Phase II
All Other|Cancer
Brain
Michael Duma, M.D.
Aivita Biomedical, Inc.
Chi Nguyen
  • Hoag Research
  • xSJH Southern California